Teicher BA - Search Results

1

TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.

Zhang Q, Chen L, Helfand BT, Jang TL, Sharma V, Kozlowski J, Kuzel TM, Zhu LJ, Yang XJ, Javonovic B, Guo Y, Lonning S, Harper J, Teicher BA, Brendler C, Yu N, Catalona WJ, Lee C. Zhang Q, et al. Among authors: teicher ba. PLoS One. 2011;6(9):e25168. doi: 10.1371/journal.pone.0025168. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21980391 Free PMC article.

2

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta.

Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X, Zhang Q, Lonning S, Teicher BA, Lee C. Liu VC, et al. Among authors: teicher ba. J Immunol. 2007 Mar 1;178(5):2883-92. doi: 10.4049/jimmunol.178.5.2883. J Immunol. 2007. PMID: 17312132

3

Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.

Perry K, Wong L, Liu V, Park I, Zhang Q, Rejen V, Huang X, Smith ND, Jovanovic B, Lonning S, Teicher BA, Lee C. Perry K, et al. Among authors: teicher ba. Urology. 2008 Jul;72(1):225-9. doi: 10.1016/j.urology.2007.11.091. Epub 2008 Mar 4. Urology. 2008. PMID: 18295867

4

TGF-beta in cancer and as a therapeutic target.

Pinkas J, Teicher BA. Pinkas J, et al. Among authors: teicher ba. Biochem Pharmacol. 2006 Aug 28;72(5):523-9. doi: 10.1016/j.bcp.2006.03.004. Epub 2006 Mar 10. Biochem Pharmacol. 2006. PMID: 16620790

5

Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies.

Rouleau C, Gianolio DA, Smale R, Roth SD, Krumbholz R, Harper J, Munroe KJ, Green TL, Horten BC, Schmid SM, Teicher BA. Rouleau C, et al. Among authors: teicher ba. Mol Cancer Ther. 2015 Sep;14(9):2081-9. doi: 10.1158/1535-7163.MCT-15-0312. Epub 2015 Jul 16. Mol Cancer Ther. 2015. PMID: 26184481

6

Transforming growth factor-beta in in vivo resistance.

Teicher BA, Holden SA, Ara G, Chen G. Teicher BA, et al. Cancer Chemother Pharmacol. 1996;37(6):601-9. doi: 10.1007/s002800050435. Cancer Chemother Pharmacol. 1996. PMID: 8612316

7

Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin.

Teicher BA, Maehara Y, Kakeji Y, Ara G, Keyes SR, Wong J, Herbst R. Teicher BA, et al. Int J Cancer. 1997 Mar 28;71(1):49-58. doi: 10.1002/(sici)1097-0215(19970328)71:1<49::aid-ijc10>3.0.co;2-4. Int J Cancer. 1997. PMID: 9096665

8

Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma.

Kakeji Y, Maehara Y, Ikebe M, Teicher BA. Kakeji Y, et al. Among authors: teicher ba. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1115-23. doi: 10.1016/s0360-3016(96)00573-1. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169821

9

Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.

Liu P, Menon K, Alvarez E, Lu K, Teicher BA. Liu P, et al. Among authors: teicher ba. Int J Oncol. 2000 Mar;16(3):599-610. doi: 10.3892/ijo.16.3.599. Int J Oncol. 2000. PMID: 10675495

10

Protein kinase C as a therapeutic target.

Teicher BA. Teicher BA. Clin Cancer Res. 2006 Sep 15;12(18):5336-45. doi: 10.1158/1078-0432.CCR-06-0945. Clin Cancer Res. 2006. PMID: 17000666 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters